All Stories

  1. Pharmacokinetics, effectiveness, tolerability and effect on quality of life of open-label tofacitinib for the treatment of moderately active mucocutaneous manifestations of SLE: results of a 76-week phase II study

    Article • Lupus Science & Medicine, July 2025, BMJ

    Dr Nora G Singer, Prof Bin Huang

  2. CDCP1 on Dendritic Cells Contributes to the Development of a Model of Kawasaki Disease

    Article • The Journal of Immunology, June 2021, Oxford University Press (OUP)

    Dr Nora G Singer

  3. A Point-of-Care Raman Spectroscopy-Based Device for the Diagnosis of Gout and Pseudogout: Comparison With the Clinical Standard Microscopy

    Article • Arthritis & Rheumatology, June 2016, Wiley

    Dr Nora G Singer

  4. Development of a Functional Biomarker for Use in Cell-Based Therapy Studies in Seropositive Rheumatoid Arthritis

    Article • Stem Cells Translational Medicine, March 2016, Wiley

    Dr Nora G Singer

  5. Validation of the Lupus Nephritis Clinical Indices in Childhood-Onset Systemic Lupus Erythematosus

    Article • Arthritis Care & Research, January 2016, Wiley

    Dr Nora G Singer

  6. Evaluation of musculoskeletal complaints in children

    Article • January 2015, Elsevier

    Dr Nora G Singer

  7. Evaluation of musculoskeletal complaints in children

    Article • January 2015, Elsevier

    Dr Nora G Singer

  8. Effects of obesity on health-related quality of life in juvenile-onset systemic lupus erythematosus

    Article • Lupus, October 2014, SAGE Publications

    Dr Nora G Singer

  9. Vitamin D status is a determinant of atorvastatin effect on carotid intima medial thickening progression rate in children with lupus: an Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) substudy

    Article • Lupus Science & Medicine, September 2014, BMJ

    Dr Nora G Singer

  10. Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Rilonacept in the Treatment of Systemic Juvenile Idiopathic Arthritis

    Article • Arthritis & Rheumatology, August 2014, Wiley

    Dr Nora G Singer

  11. Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, March 2014, New England Journal of Medicine (NEJM/MMS)

    Dr Nora G Singer

  12. Laser wavelength dependence of background fluorescence in Raman spectroscopic analysis of synovial fluid from symptomatic joints

    Article • Journal of Raman Spectroscopy, July 2013, Wiley

    Shan Yang, Dr Nora G Singer

  13. Anti-glomerular basement membrane antibody disease treated with rituximab: A case-based review

    Article • Seminars in Arthritis and Rheumatism, June 2013, Elsevier

    Dr Nora G Singer

  14. Tocilizumab in Pediatric Rheumatology: The Clinical Experience

    Article • Current Rheumatology Reports, May 2013, Springer Science + Business Media

    Dr Nora G Singer

  15. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2012

    Article • Annals of the Rheumatic Diseases, March 2013, BMJ

    Dr Nora G Singer

  16. Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein

    Article • Annals of the Rheumatic Diseases, February 2013, BMJ

    Dr Nora G Singer

  17. Validation of the systemic lupus erythematosus responder index for use in juvenile-onset systemic lupus erythematosus

    Article • Annals of the Rheumatic Diseases, January 2013, BMJ

    Dr Nora G Singer

  18. Do Adult Disease Severity Subclassifications Predict Use of Cyclophosphamide in Children with ANCA-associated Vasculitis? An Analysis of ARChiVe Study Treatment Decisions

    Article • The Journal of Rheumatology, August 2012, The Journal of Rheumatology

    Dr Nora G Singer

  19. Increased Sensitivity of the European Medicines Agency Algorithm for Classification of Childhood Granulomatosis with Polyangiitis

    Article • The Journal of Rheumatology, May 2012, The Journal of Rheumatology

    Dr Nora G Singer

  20. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011

    Article • Annals of the Rheumatic Diseases, March 2012, BMJ

    Dr Nora G Singer

  21. Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus

    Article • Arthritis Care & Research, February 2012, Wiley

    Dr Nora G Singer

  22. Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial

    Article • Arthritis Research & Therapy, January 2012, Springer Science + Business Media

    Dr Nora G Singer

  23. Algorithm development for corticosteroid management in systemic juvenile idiopathic arthritis trial using consensus methodology

    Article • Pediatric Rheumatology, January 2012, Springer Science + Business Media

    Dr Nora G Singer

  24. Use of atorvastatin in systemic lupus erythematosus in children and adolescents

    Article • Arthritis & Rheumatism, December 2011, Wiley

    Dr Nora G Singer

  25. Preliminary criteria for global flares in childhood-onset systemic lupus erythematosus

    Article • Arthritis Care & Research, August 2011, Wiley

    Dr Nora G Singer

  26. Mesenchymal Stem Cells: Mechanisms of Inflammation

    Article • Annual Review of Pathology Mechanisms of Disease, February 2011, Annual Reviews

    Dr Nora G Singer

  27. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

    Article • Annals of the Rheumatic Diseases, February 2011, BMJ

    Dr Nora G Singer

  28. Evaluation of musculoskeletal complaints in children

    Article • January 2011, Elsevier

    Dr Nora G Singer

  29. Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort

    Article • Lupus, September 2010, SAGE Publications

    Dr Nora G Singer

  30. Clinical efficacy and safety of glucosamine, chondroitin sulphate, their combination, celecoxib or placebo taken to treat osteoarthritis of the knee: 2-year results from GAIT

    Article • Annals of the Rheumatic Diseases, June 2010, BMJ

    Dr Nora G Singer

  31. Performance of rheumatoid arthritis disease activity measures and juvenile arthritis disease activity scores in polyarticular-course juvenile idiopathic arthritis: Analysis of their ability to classify the American College of Rheumatology pediatric measur

    Article • Arthritis Care & Research, March 2010, Wiley

    Dr Nora G Singer

  32. Toward the development of criteria for global flares in juvenile systemic lupus erythematosus

    Article • Arthritis Care & Research, February 2010, Wiley

    Dr Nora G Singer

  33. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009

    Article • Annals of the Rheumatic Diseases, December 2009, BMJ

    Dr Nora G Singer

  34. Associations between the American College of Rheumatology pediatric response measures and the continuous measures of disease activity used in adult rheumatoid arthritis: A secondary analysis of clinical trial data from children with Polyarticular-Cours...

    Article • Arthritis & Rheumatism, December 2009, Wiley

    Dr Nora G Singer

  35. Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood

    Article • Arthritis & Rheumatism, November 2009, Wiley

    Dr Nora G Singer

  36. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity

    Article • Arthritis & Rheumatism, September 2009, Wiley

    Dr Nora G Singer

  37. Long-term safety and effectiveness of etanercept in children with selected categories of juvenile idiopathic arthritis

    Article • Arthritis & Rheumatism, September 2009, Wiley

    Dr Nora G Singer

  38. Premature atherosclerosis in pediatric systemic lupus erythematosus: Risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort

    Article • Arthritis & Rheumatism, May 2009, Wiley

    Dr Nora G Singer

  39. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008

    Article • Annals of the Rheumatic Diseases, November 2008, BMJ

    Dr Nora G Singer

  40. The effect of glucosamine and/or chondroitin sulfate on the progression of knee osteoarthritis: A report from the glucosamine/chondroitin arthritis intervention trial

    Article • Arthritis & Rheumatism, October 2008, Wiley

    Dr Nora G Singer

  41. Sjögren’s syndrome in childhood

    Article • Current Rheumatology Reports, April 2008, Springer Science + Business Media

    Dr Nora G Singer

  42. Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis

    Article • Pediatric Nephrology, January 2008, Springer Science + Business Media

    Dr Nora G Singer

  43. Rasmussen syndrome and CNS granulomatous disease with NOD2/CARD15 mutations

    Article • Neurology, August 2007, Wolters Kluwer Health

    Dr Nora G Singer

  44. CD166 Expression, Characterization, and Localization in Salivary Epithelium: Implications for Function During Sialoadenitis

    Article • Journal of Clinical Immunology, January 2006, Springer Science + Business Media

    Dr Nora G Singer

  45. Critical Care Myopathy in a Child

    Article • JCR Journal of Clinical Rheumatology, April 2005, Wolters Kluwer Health

    Dr Nora G Singer

  46. Remittive agents in pediatric rheumatology

    Article • Current Opinion in Rheumatology, September 2004, Wolters Kluwer Health

    Dr Nora G Singer

  47. Evidence for the expression of a second CD6 ligand by synovial fibroblasts

    Article • Arthritis & Rheumatism, February 2000, Wiley

    Dr Nora G Singer

  48. Prevention of infectious complications in rheumatic disease patients

    Article • Current Opinion in Rheumatology, May 1999, Wolters Kluwer Health

    Dr Nora G Singer

  49. Update on immunosuppressive therapy

    Article • Current Opinion in Rheumatology, May 1998, Wolters Kluwer Health

    Dr Nora G Singer

  50. Immunosuppressive drug treatment

    Article • Current Opinion in Rheumatology, May 1997, Wolters Kluwer Health

    Dr Nora G Singer

  51. CD6 dependent interactions of T cells and keratinocytes: functional evidence for a second CD6 ligand on γ-interferon activated keratinocytes

    Article • Immunology Letters, May 1997, Elsevier

    Dr Nora G Singer

  52. Responsiveness of human T lymphocytes to bacterial superantigens presented by cultured rheumatoid arthritis synoviocytes

    Article • Arthritis & Rheumatism, January 1996, Wiley

    Dr Nora G Singer

  53. Mouse CD6: sequence of cDNA and expression of mRNA

    Article • Immunology Letters, January 1996, Elsevier

    Dr Nora G Singer

  54. Structures on the cell surface. Update from the fifth international workshop on human leukocyte differentiation antigens

    Article • Arthritis & Rheumatism, December 1994, Wiley

    Dr Nora G Singer